Home / Publication / Population Pharmacokinetics of Teicoplanin in Hospitalized Elderly Patients Using Cystatin C as an Indicator of Renal Function

論文

Population Pharmacokinetics of Teicoplanin in Hospitalized Elderly Patients Using Cystatin C as an Indicator of Renal Function

Author(s): Hidefumi Kasai, Yasuhiro Tsuj, Yoichi Hiraki, Moeko Tsuruyama, Hideto To, Yoshihiro Yamamoto

Year: 2018年4月1日

How Model-informed drug development rescue projects from a risky situation

事例紹介

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

ウェビナー

Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis

ウェビナー

Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer

論文

Powered by Translations.com GlobalLink Web Software

Population Pharmacokinetics of Teicoplanin in Hospitalized Elderly Patients Using Cystatin C as an Indicator of Renal Function

Population Pharmacokinetics of Teicoplanin in Hospitalized Elderly Patients Using Cystatin C as an Indicator of Renal Function

How Model-informed drug development rescue projects from a risky situation

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis

Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer

メルマガ登録

クイックアクセス

ソリューション

お問合せ

Population Pharmacokinetics of Teicoplanin in Hospitalized Elderly Patients Using Cystatin C as an Indicator of Renal Function

How Model-informed drug development rescue projects from a risky situation​

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis

Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer

メルマガ登録

クイックアクセス

ソリューション

お問合せ

How Model-informed drug development rescue projects from a risky situation